Effective VA-ECMO Intervention for Severe Cardiotoxicity Induced by Neoadjuvant Paclitaxel and Cisplatin in Laryngeal Cancer: A Case Study - Quiz - MDSpire

Effective VA-ECMO Intervention for Severe Cardiotoxicity Induced by Neoadjuvant Paclitaxel and Cisplatin in Laryngeal Cancer: A Case Study

  • By

  • Yan Qian

  • Youjun Pan

  • Zhiru Che

  • Ke Fang

  • Yingya Cao

  • Xiaogan Jiang

  • Weihua Lu

  • Qiancheng Xu

  • December 15, 2025

  • 0 min

Share

Original Source(s)

Effective VA-ECMO Intervention for Severe Cardiotoxicity Induced by Neoadjuvant Paclitaxel and Cisplatin in Laryngeal Cancer: A Case Study

  • by Yan Qian, Youjun Pan, Zhiru Che, Ke Fang, Yingya Cao, Xiaogan Jiang, Weihua Lu, Qiancheng Xu

  • December 15, 2025

Related Content

Vaccination in patients with heart failure in practice

Cardiac magnetic resonance shows increased adverse ventricular remodeling in younger patients after ST-segment elevation myocardial infarction

Shared genetic associations and aetiology between obstructive sleep apnoea and cardiovascular diseases: a genome-wide cross-trait analysis and bidirectional Mendelian randomization analysis